Email Address / User Name:
Password:
 


REGISTER HERE

Why Register?
SqueezeTrigger Info
Naked Short Exposed
Naked Short Update
Naked Short Proof
Phantom Shares
TV commercial
Cramer on Shorts
No Short List
New Short Rules
New Reg SHO
SEC Enforces SHO
New UpTick Rule
Services
  SqueezeTrigger Data
Naked Short Data
SqueezeTrigger    Alerts!
SqueezeTrigger    Reports
SqueezeTrigger    Portfolio
Naked Short List
  New to List
Buyin Imminent
Off List Today

Trade Signals
Performance
  by date
  2013-05-22
2013-05-21
2013-05-20
2013-05-17
2013-05-16
2013-05-15
2013-05-14
2013-05-13
2013-05-10
2013-05-09
2013-05-08
2013-05-07
2013-05-06
2013-05-03
2013-05-02
2013-05-01
2013-04-30
2013-04-29
2013-04-26
2013-04-25
  by exchange
  NASDAQ
AMEX
NYSE
Press Releases
  Naked Short News
SqueezeTrigger News
Friction Factor News
All Releases
Articles
  Bloomberg Article
NY Post Article
New Buyin Rule
Naked Short Article
Naked Short Survey
Naked Shorts Beware
RegSHO Amendment
RegSHO Updated
RegSHO Legal Study
  Contact Us
About Us

Symbol :

Listed 3 Consecutive Market Days. On List as of 01/23/2012 Through 01/26/2012

Current Quote*

Last: $6.810
Volume: 19,941,183

As Of: 2013-05-23 13:38:49 ET
*Quotes delayed by 20min.

Mannkind Corp (NASDAQ:MNKD)
Industry: Healthcare

MannKind Corporation, a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate, AFREZZA inhalation powder, an ultra rapid-acting insulin therapy that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MKC1106-MT, an investigational cancer immunotherapy product, which is in Phase II clinical trials; and MKC204, which is in preclinical development stage for the treatment of malignancies and inflammatory diseases. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.


Realtime Data


BuyIns.Net Releases for Symbol MNKD



3 Month

6 Month

1 Year